TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Single-Photon Emission Computed Tomography (SPECT) Market, by Type
6.1 Introduction
6.2 Hybrid SPECT Systems
6.3 Standalone SPECT Systems
Chapter 7. Global Single-Photon Emission Computed Tomography (SPECT) Market, by Application
7.1 Introduction
7.2 Oncology
7.3 Cardiology
7.4 Neurology
7.5 Others
Chapter 8. Global Single-Photon Emission Computed Tomography (SPECT) Market, by End User
8.1 Introduction
8.2 Hospitals
8.3 Diagnostic Imaging Centers
8.4 Academic & Research Centers
8.5 Others
Chapter 9. Global Single-Photon Emission Computed Tomography (SPECT) Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 UK
9.3.1.3 Italy
9.3.1.4 France
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 The Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11 Company Profiles
11.1 Koninklijke Philips N.V (The Netherlands)
11.1.1 Company Overview
11.1.2 Type Overview
11.1.3 Financials
11.2.4 Key Developments
11.1.5 SWOT Analysis
11.2 Siemens (Germany)
11.2.1 Company Overview
11.2.2 Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Positron Corporation (U.S)
11.3.1 Company Overview
11.3.2 Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Neusoft Medical Systems
11.4.1 Company Overview
11.4.2 Type/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Digirad Corporation
11.5.1 Company Overview
11.5.2 Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Gamma Medica Inc.
11.6.1 Company Overview
11.6.2 Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 GE Healthcare
11.7.1 Overview
11.7.2 Type Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Oncovision
11.8.1 Overview
11.8.2 Type Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Bruker Corporation
11.9.1 Overview
11.9.2 Type Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Mediso Ltd.
11.10.1 Overview
11.10.2 Type Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Others.
Chapter 12 Appendix
LIST OF TABLES
TABLE 1 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET INDUSTRY SYNOPSIS, 2023-2032
TABLE 2 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ESTIMATES & FORECAST, 2023-2032, (USD MILLION)
TABLE 3 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY REGION, 2023-2032, (USD MILLION)
TABLE 4 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 5 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 6 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 7 NORTH AMERICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 8 NORTH AMERICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 9 NORTH AMERICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 10 US: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 11 US: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 12 US: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 13 CANADA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 14 CANADA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 15 CANADA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 16 SOUTH AMERICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 17 SOUTH AMERICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 18 SOUTH AMERICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 19 EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, TYPE, 2023-2032, (USD MILLION)
TABLE 20 EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, APPLICATION, 2023-2032, (USD MILLION)
TABLE 21 EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 22 WESTERN EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 23 WESTERN EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 24 WESTERN EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 25 EASTERN EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 26 EASTERN EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 27 EASTERN EUROPE: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 28 ASIA-PACIFIC: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 29 ASIA-PACIFIC: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 30 ASIA-PACIFIC: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE, 2023-2032, (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION, 2023-2032, (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER, 2023-2032, (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 SEGMENTATION FOR THE GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET
FIGURE 4 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SHARE, BY TYPE 2020
FIGURE 5 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SHARE, BY APPLICATION 2020
FIGURE 6 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SHARE, BY END USER, 2020
FIGURE 7 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SHARE, BY REGION, 2020
FIGURE 8 NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SHARE, BY COUNTRY, 2020
FIGURE 9 EUROPE PRESCRIBED HEALTH APPS SHARE, BY COUNTRY, 2020
FIGURE 10 ASIA-PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SHARE, BY COUNTRY, 2020
FIGURE 11 MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SHARE, BY COUNTRY, 2020
FIGURE 12 GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 13 KONINKLIJKE PHILIPS N.V.: KEY FINANCIALS
FIGURE 14 KONINKLIJKE PHILIPS N.V.: SEGMENTAL REVENUE
FIGURE 15 KONINKLIJKE PHILIPS N.V: GEOGRAPHICAL REVENUE
FIGURE 16 SIEMENS.: KEY FINANCIALS
FIGURE 17 SIEMENS.: SEGMENTAL REVENUE
FIGURE 18 SIEMENS.: GEOGRAPHICAL REVENUE
FIGURE 19 POSITRON CORPORATION.: KEY FINANCIALS
FIGURE 20 POSITRON CORPORATION.: SEGMENTAL REVENUE
FIGURE 21 POSITRON CORPORATION.: GEOGRAPHICAL REVENUE
FIGURE 22 NEUSOFT MEDICAL SYSTEMS: KEY FINANCIALS
FIGURE 23 NEUSOFT MEDICAL SYSTEMS: SEGMENTAL REVENUE
FIGURE 24 NEUSOFT MEDICAL SYSTEMS: GEOGRAPHICAL REVENUE
FIGURE 25 DIGIRAD CORPORATION.: KEY FINANCIALS
FIGURE 26 DIGIRAD CORPORATION.: SEGMENTAL REVENUE
FIGURE 27 DIGIRAD CORPORATION.: GEOGRAPHICAL REVENUE
FIGURE 28 GAMMA MEDICA INC.: KEY FINANCIALS
FIGURE 29 GAMMA MEDICA INC.: SEGMENTAL REVENUE
FIGURE 30 GAMMA MEDICA INC.: GEOGRAPHICAL REVENUE
FIGURE 31 MEDTRONIC PLC : KEY FINANCIALS
FIGURE 32 MEDTRONIC PLC: SEGMENTAL REVENUE
FIGURE 33 MEDTRONIC PLC : GEOGRAPHICAL REVENUE